Patents by Inventor Kjetil Hestdal

Kjetil Hestdal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF PHOTODYNAMIC THERAPY (PDT) FOR BLADDER CANCER
    Publication number: 20220152411
    Abstract: This invention relates to a method of photodynamic therapy (PDT) for bladder cancer and its use as an adjuvant or neoadjuvant therapy in the treatment of bladder cancer. The invention provides a composition comprising hexyl 5-ALA ester (HAL) or a pharmaceutically acceptable salt thereof for use in a method of photodynamic therapy for bladder cancer, wherein said composition is instilled into the bladder of a patient in need of such treatment and the inside of said bladder is exposed to blue light having a fluence rate of 1.5 to 12.5 mW/cm2.
    Type: Application
    Filed: January 31, 2022
    Publication date: May 19, 2022
    Inventors: Kjetil Hestdal, Aslak Godal
  • Neoadjuvant therapy for bladder cancer
    Patent number: 11311620
    Abstract: This invention relates to a neoadjuvant therapy for bladder cancer in bladder cancer patients who are scheduled for a cystectomy and methods of carrying out such a neoadjuvant therapy. In particular, the invention relates to a composition comprising hexyl 5-ALA ester (HAL) or a pharmaceutically acceptable salt thereof for use in a neoadjuvant therapy for bladder cancer in a bladder cancer patient who is scheduled for a cystectomy, the therapy comprises instilling said composition into the bladder of said patient and exposing the inside of said bladder to light.
    Type: Grant
    Filed: January 21, 2020
    Date of Patent: April 26, 2022
    Assignee: PHOTOCURE ASA
    Inventor: Kjetil Hestdal
  • Method of photodynamic therapy (PDT) for bladder cancer
    Patent number: 11235168
    Abstract: This invention relates to a method of photodynamic therapy (PDT) for bladder cancer and its use as an adjuvant or neoadjuvant therapy in the treatment of bladder cancer. The invention provides a composition comprising hexyl 5-ALA ester (HAL) or a pharmaceutically acceptable salt thereof for use in a method of photodynamic therapy for bladder cancer, wherein said composition is instilled into the bladder of a patient in need of such treatment and the inside of said bladder is exposed to blue light having a fluence rate of 1.5 to 12.5 mW/cm2.
    Type: Grant
    Filed: December 19, 2016
    Date of Patent: February 1, 2022
    Assignee: PHOTOCURE ASA
    Inventors: Kjetil Hestdal, Aslak Godal
  • Intravesical therapy for bladder cancer
    Patent number: 11066478
    Abstract: This invention relates to an intravesical therapy for bladder cancer.
    Type: Grant
    Filed: April 18, 2019
    Date of Patent: July 20, 2021
    Assignee: PHOTOCURE ASA
    Inventor: Kjetil Hestdal
  • NEOADJUVANT THERAPY FOR BLADDER CANCER
    Publication number: 20200155683
    Abstract: This invention relates to a neoadjuvant therapy for bladder cancer in bladder cancer patients who are scheduled for a cystectomy and methods of carrying out such a neoadjuvant therapy. In particular, the invention relates to a composition comprising hexyl 5-ALA ester (HAL) or a pharmaceutically acceptable salt thereof for use in a neoadjuvant therapy for bladder cancer in a bladder cancer patient who is scheduled for a cystectomy, the therapy comprises instilling said composition into the bladder of said patient and exposing the inside of said bladder to light.
    Type: Application
    Filed: January 21, 2020
    Publication date: May 21, 2020
    Inventor: Kjetil Hestdal
  • Neoadjuvant therapy for bladder cancer
    Patent number: 10556010
    Abstract: This invention relates to a neoadjuvant therapy for bladder cancer in bladder cancer patients who are scheduled for a cystectomy and methods of carrying out such a neoadjuvant therapy. In particular the invention relates to a composition comprising hexyl 5-ALA ester (HAL) or a pharmaceutically acceptable salt thereof for use in a neoadjuvant therapy for bladder cancer in a bladder cancer patient who is scheduled for a cystectomy, the therapy comprises instilling said composition into the bladder of said patient and exposing the inside of said bladder to light.
    Type: Grant
    Filed: December 19, 2016
    Date of Patent: February 11, 2020
    Assignee: PHOTOCURE ASA
    Inventor: Kjetil Hestdal
  • INTRAVESICAL THERAPY FOR BLADDER CANCER
    Publication number: 20190241672
    Abstract: This invention relates to an intravesical therapy for bladder cancer.
    Type: Application
    Filed: April 18, 2019
    Publication date: August 8, 2019
    Inventor: Kjetil Hestdal
  • METHOD OF PHOTODYNAMIC THERAPY (PDT) FOR BLADDER CANCER
    Publication number: 20190022404
    Abstract: This invention relates to a method of photodynamic therapy (PDT) for bladder cancer and its use as an adjuvant or neoadjuvant therapy in the treatment of bladder cancer. The invention provides a composition comprising hexyl 5-ALA ester (HAL) or a pharmaceutically acceptable salt thereof for use in a method of photodynamic therapy for bladder cancer, wherein said composition is instilled into the bladder of a patient in need of such treatment and the inside of said bladder is exposed to blue light having a fluence rate of 1.5 to 12.
    Type: Application
    Filed: December 19, 2016
    Publication date: January 24, 2019
    Inventors: Kjetil Hestdal, Aslak Godal
  • INTRAVESICAL THERAPY FOR BLADDER CANCER
    Publication number: 20180371101
    Abstract: This invention relates to an intravesical therapy for bladder cancer.
    Type: Application
    Filed: December 19, 2016
    Publication date: December 27, 2018
    Applicant: PHOTOCURE ASA
    Inventor: Kjetil Hestdal
  • NEOADJUVANT THERAPY FOR BLADDER CANCER
    Publication number: 20180369379
    Abstract: This invention relates to a neoadjuvant therapy for bladder cancer in bladder cancer patients who are scheduled for a cystectomy and methods of carrying out such a neoadjuvant therapy. In particular the invention relates to a composition comprising hexyl 5-ALA ester (HAL) or a pharmaceutically acceptable salt thereof for use in a neoadjuvant therapy for bladder cancer in a bladder cancer patient who is scheduled for a cystectomy, the therapy comprises instilling said composition into the bladder of said patient and exposing the inside of said bladder to light.
    Type: Application
    Filed: December 19, 2016
    Publication date: December 27, 2018
    Inventor: Kjetil Hestdal